Last Updated : June 1, 2023
Details
FilesProject Status:
Complete
Therapeutic Area:
Non-Small Cell Lung Cancer (NSCLC) with Activating Epidermal Growth Factor Receptor (EGFR) Mutations
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0028-000
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | March 30, 2023 |
| Stakeholder Feedback Deadline: | April 6, 2023 |
| Final Report Posted: | June 1, 2023 |
Additional time is required to improve the clarity of the algorithm based on stakeholder feedback
Files
Last Updated : June 1, 2023